These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
232 related articles for article (PubMed ID: 8859188)
1. Near tetraploid prostate carcinoma. Methodologic and prognostic aspects. Forsslund G; Nilsson B; Zetterberg A Cancer; 1996 Oct; 78(8):1748-55. PubMed ID: 8859188 [TBL] [Abstract][Full Text] [Related]
2. Ploidy level determinations in high-grade and low-grade malignant variants of prostatic carcinoma. Forsslund G; Zetterberg A Cancer Res; 1990 Jul; 50(14):4281-5. PubMed ID: 1694718 [TBL] [Abstract][Full Text] [Related]
3. A DNA cytometric proliferation index improves the value of the DNA ploidy pattern as a prognosticating tool in patients with carcinoma of the prostate. Ahlgren G; Lindholm K; Falkmer U; Abrahamsson PA Urology; 1997 Sep; 50(3):379-84. PubMed ID: 9301701 [TBL] [Abstract][Full Text] [Related]
4. Prognostic significance of DNA ploidy and proliferation in 309 colorectal carcinomas as determined by two-color multiparametric DNA flow cytometry. Zarbo RJ; Nakhleh RE; Brown RD; Kubus JJ; Ma CK; Mackowiak P Cancer; 1997 Jun; 79(11):2073-86. PubMed ID: 9179053 [TBL] [Abstract][Full Text] [Related]
5. DNA ploidy and proliferation heterogeneity in human prostate cancers. Shankey TV; Jin JK; Dougherty S; Flanigan RC; Graham S; Pyle JM Cytometry; 1995 Sep; 21(1):30-9. PubMed ID: 8529468 [TBL] [Abstract][Full Text] [Related]
6. [The clinical usefulness of flow cytometric DNA analysis in prostatic cancer]. Ishikawa A Hinyokika Kiyo; 1992 Jun; 38(6):665-70. PubMed ID: 1632320 [TBL] [Abstract][Full Text] [Related]
7. Prognostic significance of tumor DNA content in carcinoma of the hepatic duct confluence. Sato Y; van Gulik TM; Bosma A; Lygidakis NJ; Koyama K; van der Heyde MN Surgery; 1994 Apr; 115(4):488-94. PubMed ID: 8165540 [TBL] [Abstract][Full Text] [Related]
8. Ploidy level and tumor progression in prostatic carcinoma. Zetterberg A; Forsslund G Acta Oncol; 1991; 30(2):193-9. PubMed ID: 2029404 [TBL] [Abstract][Full Text] [Related]
9. Relationship between DNA ploidy, glandular differentiation, and tumor spread in human prostate cancer. Frankfurt OS; Chin JL; Englander LS; Greco WR; Pontes JE; Rustum YM Cancer Res; 1985 Mar; 45(3):1418-23. PubMed ID: 3971384 [TBL] [Abstract][Full Text] [Related]
10. DNA ploidy is a valuable predictor for prognosis of patients with resected renal cell carcinoma. Abou-Rebyeh H; Borgmann V; Nagel R; Al-Abadi H Cancer; 2001 Nov; 92(9):2280-5. PubMed ID: 11745282 [TBL] [Abstract][Full Text] [Related]
11. DNA image analysis of urinary cytology: prediction of recurrent transitional cell carcinoma. de la Roza GL; Hopkovitz A; Caraway NP; Kidd L; Dinney CP; Johnston D; Katz RL Mod Pathol; 1996 May; 9(5):571-8. PubMed ID: 8733774 [TBL] [Abstract][Full Text] [Related]
12. Clinical utility of cellular DNA measurements in prostate carcinoma. Consensus Conference on Diagnosis and Prognostic Parameters in Localized Prostate Cancer. Stockholm, Sweden, May 12-13, 1993. Schröder F; Tribukait B; Böcking A; DeVere White R; Koss L; Lieber M; Stenkvist B; Zetterberg A Scand J Urol Nephrol Suppl; 1994; 162():51-63; discussion 15-27. PubMed ID: 7529429 [TBL] [Abstract][Full Text] [Related]
13. DNA ploidy of spindle cell soft-tissue tumors and its relationship to histology and clinical outcome. Agarwal V; Greenebaum E; Wersto R; Koss LG Arch Pathol Lab Med; 1991 Jun; 115(6):558-62. PubMed ID: 2039341 [TBL] [Abstract][Full Text] [Related]
14. Prognostic value of static cytometry in transitional cell carcinoma of the bladder: recurrence rate and survival in a group of patients at 10 years follow-up. Cai T; Margallo E; Nesi G; Giubilei G; Rizzo M; Bartoletti R Oncol Rep; 2006 Jan; 15(1):213-9. PubMed ID: 16328058 [TBL] [Abstract][Full Text] [Related]
15. Prognostic value of DNA ploidy: 5-year follow-up of patients with resectable squamous cell carcinoma (SCC) of the lung. Kasprzyk M; Dyszkiewicz W; Piwkowski C; Gasiorowski L; Kaczmarek E Lung Cancer; 2006 Feb; 51(2):201-6. PubMed ID: 16375987 [TBL] [Abstract][Full Text] [Related]
16. The significance of tumor heterogeneity for prediction of DNA ploidy of prostate cancer. Häggarth L; Auer G; Busch C; Norberg M; Häggman M; Egevad L Scand J Urol Nephrol; 2005; 39(5):387-92. PubMed ID: 16257840 [TBL] [Abstract][Full Text] [Related]
17. The prognostic significance of ploidy and DNA-heterogeneity in the primary diagnosis and monitoring of patients with locally advanced prostatic carcinoma. Nagel R; al Abadi H Scand J Urol Nephrol Suppl; 1991; 138():83-92. PubMed ID: 1785025 [TBL] [Abstract][Full Text] [Related]
18. Near-diploidy: a new prognostic factor for clinically localized prostate cancer treated with external beam radiation therapy. Pollack A; Zagars GK; el-Naggar AK; Gauwitz MD; Terry NH Cancer; 1994 Apr; 73(7):1895-903. PubMed ID: 7511039 [TBL] [Abstract][Full Text] [Related]
19. Prognostic value of S-phase fraction in lymph-node-negative breast cancer by image and flow cytometric analysis. Peiró G; Lerma E; Climent MA; Seguí MA; Alonso MC; Prat J Mod Pathol; 1997 Mar; 10(3):216-22. PubMed ID: 9071729 [TBL] [Abstract][Full Text] [Related]
20. Ten-year results of a prospective study on the prognostic role of ploidy in endometrial carcinoma: dNA aneuploidy identifies high-risk cases among the so-called 'low-risk' patients with well and moderately differentiated tumors. Susini T; Amunni G; Molino C; Carriero C; Rapi S; Branconi F; Marchionni M; Taddei G; Scarselli G Cancer; 2007 Mar; 109(5):882-90. PubMed ID: 17262824 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]